Chronic kidney disease: Actin cytoskeleton alterations in podocytes: A therapeutic target for chronic kidney disease

Nature Reviews Nephrology

Volumn 11, Issue 7, 2015, Pages 385-

  Allison, Susan J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIS T 23; DYNAMIN; UNCLASSIFIED DRUG; URINARY TRACT AGENT; COUMARIC ACID; CYANOACRYLATE DERIVATIVE;

ACTIN FILAMENT; CHRONIC KIDNEY DISEASE; CYTOSKELETON; DIABETIC NEPHROPATHY; DRUG MECHANISM; NONHUMAN; NOTE; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; ANIMAL; DRUG EFFECTS; HUMAN; METABOLISM; RENAL INSUFFICIENCY, CHRONIC;

ANIMALS; COUMARIC ACIDS; CYANOACRYLATES; DYNAMINS; HUMANS; PODOCYTES; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84933177480     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2015.79     Document Type: Note

References (1)

1. Schiffer, M. et al. Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models. Nat. Med. 10.1038/nm.3843